Pathophysiological and diagnostic implications of cortical dysfunction in ALS

被引:0
|
作者
Nimeshan Geevasinga
Parvathi Menon
P. Hande Özdinler
Matthew C. Kiernan
Steve Vucic
机构
[1] Western Clinical School,Davee Department of Neurology and Clinical Neurological Sciences
[2] University of Sydney,undefined
[3] Westmead Hospital,undefined
[4] Northwestern University,undefined
[5] Feinberg School of Medicine,undefined
[6] Brain and Mind Research Institute,undefined
[7] University of Sydney,undefined
来源
Nature Reviews Neurology | 2016年 / 12卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Cortical hyperexcitability is an early pathophysiological feature of amyotrophic lateral sclerosis (ALS)Cortical hyperexcitability potentially mediates motor neuron degeneration in ALS via a dying-forward, trans-synaptic, glutaminergic mechanismThe identification of the C9orf72 hexanucleotide repeat expansion as a major cause of familial and apparently sporadic ALS, as well as frontotemporal dementia, underscored the importance of cortical dysfunctionCortical hyperexcitability is an important diagnostic biomarker of ALS, and could enable more-definitive diagnosis at an earlier stage of the disease process
引用
收藏
页码:651 / 661
页数:10
相关论文
共 50 条
  • [31] Pathophysiological implications of hyperhomocysteinemia
    Quintanaa, Irene
    Genoud, Valeria
    ACTA BIOQUIMICA CLINICA LATINOAMERICANA, 2023, 57 (01): : 35 - 47
  • [33] Focal cortical dysplasia: pathophysiological approach
    Akira Hodozuka
    Hiroshige Tsuda
    Kiyotaka Hashizume
    Tatsuya Tanaka
    Child's Nervous System, 2006, 22 : 827 - 833
  • [34] Pathophysiological study of focal cortical dysplasia
    Hodozuka, Akira
    Tanaka, Tatsuya
    NEUROLOGICAL SURGERY, 2008, 36 (05): : 385 - 391
  • [35] Focal cortical dysplasia: pathophysiological approach
    Hodozuka, Akira
    Tsuda, Hiroshige
    Hashizume, Kiyotaka
    Tanaka, Tatsuya
    CHILDS NERVOUS SYSTEM, 2006, 22 (08) : 827 - 833
  • [36] Relationships between regional cortical atrophy and cognitive dysfunction in non-demented ALS patients
    Simone, IL
    Mezzapesa, DM
    Ceccarelli, A
    Tortorella, C
    Palagano, G
    De Caro, MF
    Barulli, MR
    Dicuonzo, F
    Carella, A
    Plasmati, I
    Livrea, P
    NEUROLOGY, 2005, 64 (06) : A227 - A228
  • [37] Myeloid dysfunction in ALS
    Laurie A Dempsey
    Nature Immunology, 2016, 17 (5) : 480 - 480
  • [38] Mitochondrial dysfunction in ALS
    Cozzolino, Mauro
    Carri, Maria Teresa
    PROGRESS IN NEUROBIOLOGY, 2012, 97 (02) : 54 - 66
  • [39] Gastrointestinal dysfunction in ALS
    Wingate, D
    AMYOTROPHIC LATERAL SCLEROSIS, 1999, 1 (01): : 2 - 2
  • [40] Gold Coast diagnostic criteria: Implications for ALS diagnosis and clinical trial enrollment
    Vucic, Steve
    Ferguson, Toby A.
    Cummings, Catherine
    Hotchkin, Michael T.
    Genge, Angela
    Glanzman, Robert
    Roet, Kasper C. D.
    Cudkowicz, Merit
    Kiernan, Matthew C.
    MUSCLE & NERVE, 2021, 64 (05) : 532 - 537